Multicenter, double-blind, sham endoscopy-controlled, randomized trial evaluating the efficacy of antireflux mucosal ablation for the treatment of gastroesophageal reflux disease


Por: de Santiago, ER, Sánchez-Vegazo, CT, Albéniz, E, Arévalo, FE, Gamboa, AA, Castel, I, Anta, JA, Marín-Gabriel, JC, Redondo, PD, Rodríguez, HN, De Tejada, AH, Martínez, IE, Pons, FR, Naves, JE, Uchima, H, Marín, I, Alcorta, JMD, Corte, DP, Pallarés, PD, Enciso, IP, Suarez, CG, Lorenzo-Zúñiga, V, Nogales, O, Muriel, A, Albillos, A, García, BP, Carbonell, SP, Sánchez, AM, Ganuza, M, Reina, AIR, Sanz, MD, De Frutos, D, Garcia, JS, Matallana, V, Relea, L, Priego, LB, Muñiz, MP, Bellver, VO, Lledó, JG, Hernández, JA, Segura, AM, Zamora, J, Neves, JAC and Sequeiros, EV

Publicada: 10 feb 2026 Ahead of Print: 1 feb 2026
Resumen:
Background Antireflux mucosal ablation (ARMA) is a novel endoscopic technique for gastroesophageal reflux disease (GERD) but has only been assessed in noncontrolled studies. The objective of this randomized controlled study was to evaluate its efficacy in patients with proton pump inhibitor (PPI)-responsive GERD. Methods We conducted a double-blind, sham endoscopy-controlled, randomized trial across 12 Spanish hospitals. Adults with PPI-responsive GERD and abnormal esophageal acid exposure time (AET > 6 %) were randomly assigned (1:1) to receive ARMA or sham endoscopy. The primary outcome was clinical success at 12 months, defined as a >= 50 % reduction in the GERD-Health-Related Quality of Life score. Inability to discontinue PPIs to allow symptom assessment was considered treatment failure. Secondary outcomes included PPI discontinuation, AET, manometric parameters, mucosal healing, and adverse events. Results Of 186 patients screened, 60 were included (ARMA 31; sham 29). At 12 months, clinical success was achieved in 16 patients (51.6 %) in the ARMA group and in 11 (37.9 %) in the sham group (P = 0.29; risk ratio 1.36, 95 %CI 0.76 to 2.42). No significant differences were observed in PPI discontinuation, AET, manometric findings, or mucosal healing. Postprocedural pain (27.3 % vs. 3.3 %) and dysphagia (45.5 % vs. 10.0 %) occurred more frequently in the ARMA group. No severe adverse events were recorded. Conclusions ARMA was not superior to sham endoscopy in improving GERD-related quality of life at 12 months in patients with PPI-responsive GERD, and was associated with a higher incidence of adverse events. These findings do not support its implementation in routine clinical practice.

Filiaciones:
de Santiago, ER:
 Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain

 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

 Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain

Sánchez-Vegazo, CT:
 Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain

 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

 Univ Alcala, Dept Med, Madrid, Spain

Albéniz, E:
 Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain

Arévalo, FE:
 Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain

Gamboa, AA:
 Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain

Castel, I:
 Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain

Anta, JA:
 Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain

Marín-Gabriel, JC:
 Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain

Redondo, PD:
 Hosp Rio Hortega, Dept Gastroenterol, Valladolid, Spain

Rodríguez, HN:
 Hosp Rio Hortega, Dept Gastroenterol, Valladolid, Spain

De Tejada, AH:
 Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain

Martínez, IE:
 Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain

Pons, FR:
 Hosp del Mar Res Inst, Gastroenterol Dept, Barcelona, Spain

Naves, JE:
 Hosp del Mar Res Inst, Gastroenterol Dept, Barcelona, Spain

:
 Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain

 Hosp Univ Germans Trias i Pujol, Dept Gastroenterol, Endoscopy Unit, Barcelona, Spain

:
 Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain

Alcorta, JMD:
 Hosp San Agustin, Dept Gastroenterol, Aviles, Spain

Corte, DP:
 Hosp San Agustin, Dept Gastroenterol, Aviles, Spain

Pallarés, PD:
 Hosp Univ La Paz, Gastroenterol Dept, Madrid, Spain

Enciso, IP:
 Hosp Univ La Paz, Gastroenterol Dept, Madrid, Spain

Suarez, CG:
 Hosp Cabuenes, Gastroenterol Dept, Gijon, Spain

Lorenzo-Zúñiga, V:
 Hosp Univ & Politecn La Fe, Dept Gastroenterol & Hepatol, Gastrointestinal Endoscopy Unit, Inst Invest Sanitaria La Fe, Valencia, Spain

Nogales, O:
 Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid, Spain

Muriel, A:
 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

 Univ Alcala, Dept Med, Madrid, Spain

 Hosp Ramon & Cajal, Clin Biostat Unit, Madrid, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

Albillos, A:
 Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain

 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

 Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain

García, BP:
 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

Carbonell, SP:
 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

Sánchez, AM:
 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

Ganuza, M:
 Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain

Reina, AIR:
 Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain

Sanz, MD:
 Hosp Rio Hortega, Dept Gastroenterol, Valladolid, Spain

De Frutos, D:
 Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain

Garcia, JS:
 Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain

Matallana, V:
 Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain

Relea, L:
 Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain

Priego, LB:
 Hosp del Mar Res Inst, Gastroenterol Dept, Barcelona, Spain

Muñiz, MP:
 Hosp Cabuenes, Gastroenterol Dept, Gijon, Spain

Bellver, VO:
 Hosp Univ & Politecn La Fe, Dept Gastroenterol & Hepatol, Gastrointestinal Endoscopy Unit, Inst Invest Sanitaria La Fe, Valencia, Spain

Lledó, JG:
 Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid, Spain

Hernández, JA:
 Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid, Spain

Segura, AM:
 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

Zamora, J:
 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain

 Hosp Ramon & Cajal, Clin Biostat Unit, Madrid, Spain

Neves, JAC:
 Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain

 Algarve Univ Hosp Ctr, Dept Gastroenterol, Portimao, Portugal

 Univ Algarve, Algarve Biomed Ctr, Faro, Portugal

Sequeiros, EV:
 Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain

 Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
ISSN: 14388812





Endoscopy
Editorial
Georg Thieme Verlag, RUDIGERSTR 14, D-70469 STUTTGART, GERMANY, Alemania
Tipo de documento: Article
Volumen: 58 Número: 06
Páginas: 595-607
WOS Id: 001686457200001
ID de PubMed: 41475422

MÉTRICAS